Currently out of the existing stock ratings of Supawat Thongthip, 10 are a BUY (100%).
Analyst Supawat Thongthip, currently employed at TRUIST, has had 8.33% of price targets met with an average potential upside of 1.64%, reached in 4 days on average.
Supawat Thongthip has documented 20 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AVBP, ArriVent BioPharma at 10-Nov-2026.
Analyst best performing recommendations are on AVBP (ARRIVENT BIOPHARMA).
The best stock recommendation documented was for AVBP (ARRIVENT BIOPHARMA) on 10/7/2026. The price target of $18 was fulfilled within 13 days with a profit of $1.11 (6.57%), with a performance score of 5.06.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 31-May-2024
$30
$14.31 (91.20%)
$21
12 days ago
(10-Nov-2026)
3/4 (75%)
$11.35 (60.86%)
563
Hold Since 01-Oct-2026
$23
$7.31 (46.59%)
$24
12 days ago
(10-Nov-2026)
0/2 (0%)
$4.35 (23.32%)
Buy Since 19-Dec-2023
$35
$19.31 (123.07%)
$35
26 days ago
(27-Oct-2026)
2/11 (18.18%)
$16.23 (86.47%)
14
Buy Since 12-Feb-2026
$40
$24.31 (154.94%)
$40
2 months 12 days ago
(10-Sep-2026)
0/3 (0%)
$15.03 (60.19%)
Buy Since 28-May-2026
$38
$22.31 (142.19%)
$37
3 months 10 days ago
(12-Aug-2026)
0/2 (0%)
$10.01 (35.76%)
Which stock is Supawat Thongthip most bullish on?
Which stock is Supawat Thongthip most reserved on?
What Year was the first public recommendation made by Supawat Thongthip?